Skip to main content
. 2023 Jan 6;43(5):791–800. doi: 10.1177/0271678X221148979

Table 1.

Demographic and imaging differences between individuals without history of depression, individuals with active unipolar depressive disorder, and individuals with history of depression that was in remission at time of study.

Full sample (n = 254) No depression (n = 174) Current depression (n = 36) Past depression (n = 44) Test-statistic p-value
Age (years) 41.6 ± 14.9 41.6 ± 15.4 40.9 ± 15.3 42.2 ± 12.9 F = .08 .98
Sex (M/F), (%M) 99/155 (39.0%) 79/95 (45.4%) 10/26 (27.8%) 10/34 (22.7%) χ2 = 9.80 .007
Current smoker, n 21 (8.3%) 16 (9.2%) 3 (8.3%) 2 (4.5%) χ2 = 1.00 .61
On antidepressant, n (%) 38 (15.0%) 6 (3.4%)a 20 (55.6%) 12 (27.3%) χ2 = 70.0 <.001
 – SSRI 24 (9.4%) 5 (2.9%) 13 (36.1%) 6 (13.6%)
 – SNRI 6 (2.4%) 1 (0.6%) 3 (8.3%) 2 (4.5%)
 – tricyclic 1 (0.4%) 0 0 1 (2.3%)
 – multiple 6 (2.4) 0 3 (8.3%) 3 (6.8%)
BDI 4.1 ± 4.3 14.5 ± 8.1 6.5 ± 6.1 F = 54.0b <.001
MTSD-State 0.12 ± 0.18 0.84 ± 0.73 0.18 ± 0.28 F = 67.5b <.001
MTSD-Trait 0.30 ± 0.37 1.25 ± 0.61 1.01 ± 0.79 F = 68.4b <.001
Stressful life events 2.8 ± 1.6 3.7 ± 2.0 3.5 ± 1.9 F = 4.66b .010
Total CBF 55.4 ± 9.8 53.2 ± 10.0 57.7 ± 11.3 F = 3.45b .032
Average GM CBF 59.1 ± 10.6 56.7 ± 10.9 61.5 ± 12.3 F = 3.49b .032
Average WM CBF 23.2 ± 4.6 22.1 ± 4.1 23.8 ± 4.0 F = 2.25b .11

Variance provided as standard deviation. BDI: Beck Depression Inventory; MTSD: Maryland Trait and State Depression scales; CBF: cerebral blood flow.

aTaking antidepressants for anxiety disorders in remission at time of study.

bAge, sex and smoking status included as covariates.